FLS
64
3
FFIV
67
3
AIG
69
-2
BDX
50
9
COP
33
-6
TEL
58
-2
CPB
27
2
VIX
57
3
EQT
50
-6
CB
54
3
AN
47
-2
BMY
50
2
KO
55
-12
PRU
59
2
CF
50
-6
EXPD
29
2
STX
56
12
ECL
54
5
SLB
32
-3
CAT
48
2
FLS
64
3
FFIV
67
3
AIG
69
-2
BDX
50
9
COP
33
-6
TEL
58
-2
CPB
27
2
VIX
57
3
EQT
50
-6
CB
54
3
AN
47
-2
BMY
50
2
KO
55
-12
PRU
59
2
CF
50
-6
EXPD
29
2
STX
56
12
ECL
54
5
SLB
32
-3
CAT
48
2
Financhill
Back

IDEAYA Biosciences 10K Form

Sell
39

IDYA
IDEAYA Biosciences

Last Price:
$20.50
Seasonality Move:
57.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IDYA News And Ratings

See the #1 stock for the next 7 days that we like better than IDYA

IDYA Financial Statistics

Sales & Book Value

Annual Sales: $7M
Cash Flow: $-122.8M
Price / Cash Flow: 0
Annual Sales: $12.24
Price / Book: 1.66

Profitability

EPS (TTM): -3.30000
Net Income (TTM): $-276M
Gross Margin: --
Return on Equity: -29.19%
Return on Assets: -27.88%

IDEAYA Biosciences Earnings Forecast

Key IDEAYA Biosciences Financial Ratios

  • The Research & Development expenses have been 4,209.61% of Revenue.
  • The Net Earning history of IDYA is -3,921.10% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

IDEAYA Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IDYA
CUSIP: 45166A
Website: ideayabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 14.97
Quick Ratio: 14.68

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IDYA Technical Analysis vs Fundamental Analysis

Sell
39
IDEAYA Biosciences (IDYA) is a Sell

Is IDEAYA Biosciences a Buy or a Sell?